Related Experiment Videos
Spinal cord protection: development of a paraplegia-preventive solution
T Ueno1, K Furukawa, Y Katayama
1Department of Surgery, Saga Medical School, Japan.
The Annals of Thoracic Surgery
|July 1, 1994
Summary
A novel solution combining hypothermia, methylprednisolone, mannitol, and vitamins E and C effectively protects the spinal cord from ischemic injury. This method significantly prevents paraplegia following aortic cross-clamping in rabbits.
Area of Science:
- Cardiovascular Surgery
- Neurosurgery
- Experimental Medicine
Background:
- Spinal cord ischemia and reperfusion injury can lead to paraplegia after aortic procedures.
- Current protective methods are insufficient, necessitating novel therapeutic strategies.
Purpose of the Study:
- To evaluate a clinically available method for protecting the spinal cord against ischemic/reperfusion injury.
- To prevent paraplegia after aortic cross-clamping.
Main Methods:
- Thirty-five rabbits underwent aortic occlusion for 45 minutes.
- Infusions of varying solutions, including controls, were administered distally to the occlusion site at 3°C.
- Neurologic status was assessed postoperatively using Tarlov's criteria.
Main Results:
- Groups receiving methylprednisolone, mannitol, and vitamins E and C showed significantly superior neurologic outcomes compared to controls.
- Paraplegia rates were 71% (control), 43% (Ringer's), 29% (Ringer's + methylprednisolone), 14% (Ringer's + methylprednisolone + mannitol), and 0% (Ringer's + methylprednisolone + mannitol + vitamins E and C).
- The combination solution demonstrated optimal spinal cord protection.
Conclusions:
- A multi-component solution including hypothermia, methylprednisolone, mannitol, and vitamins E and C offers significant spinal cord protection.
- This method effectively prevents paraplegia resulting from aortic cross-clamping.
- The developed neuroprotective strategy is clinically applicable.